CTXR — Citius Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Citius Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	70.1	41.7	26.5	3.25	4.25
Total Inventory
Prepaid Expenses
Total Current Assets	72.8	44.6	34.4	14.2	27.9
Net Property, Plant And Equipment	0.83	0.65	0.456	0.246	0.819
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	142	114	104	117	131
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.98	4.53	5.78	35.8	44.9
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	10.2	11.2	12.8	46.6	63.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	132	103	90.8	70.1	67.6
Total Liabilities & Shareholders' Equity	142	114	104	117	131
Total Common Shares Outstanding